文献速递炎症性肠病

系统综述与Meta分析:肠内营养治疗用于诱导儿童克罗恩病缓解

Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease.
PubMed 文献 · Aliment Pharmacol Ther · 2017-08-16

该系统综述与Meta分析检索8个在线数据库,纳入9项比较全肠内营养与皮质类固醇诱导儿童克罗恩病缓解的研究,其中8项(n=451)可提取数据进行Meta分析。全肠内营养诱导缓解的疗效与皮质类固醇相当(OR=1.26,95%CI 0.77-2.05),但全肠内营养组肠道愈合的可能性显著更高(OR=4.5,95%CI 1.64-12.32)。

要点

  • 全肠内营养诱导儿童克罗恩病缓解的疗效与皮质类固醇相当(OR=1.26,95%CI 0.77-2.05)。
  • 全肠内营养组实现肠道愈合的可能性显著高于皮质类固醇组(OR=4.5,95%CI 1.64-12.32)。
  • 生物标志物正常化(CRP、粪钙卫蛋白)两组间无显著差异。

核心结论

  • 在儿童克罗恩病群体中,全肠内营养与皮质类固醇在诱导缓解方面疗效无差异。
  • 探索性分析提示,接受全肠内营养治疗的患者中达到黏膜愈合的比例更高。

研究设计与样本

  • 系统综述与Meta分析,检索8个在线数据库,纳入9项具有比较组(全肠内营养与单纯皮质类固醇)且明确定义缓解的研究。
  • 其中8项研究(n=451)的数据可提取进入Meta分析。

主要发现

  • 全肠内营养诱导缓解的疗效与皮质类固醇相当(OR=1.26,95%CI 0.77-2.05)。
  • 新诊断克罗恩病亚组中全肠内营养与皮质类固醇疗效无差异(OR=1.61,95%CI 0.87-2.98)。
  • 复发克罗恩病亚组中全肠内营养与皮质类固醇疗效无差异(OR=0.76,95%CI 0.29-1.98)。
  • 全肠内营养组肠道愈合的可能性显著高于皮质类固醇组(OR=4.5,95%CI 1.64-12.32)。
  • 生物标志物正常化频率两组间无差异,包括CRP(OR=0.85,95%CI 0.44-1.67)和粪钙卫蛋白(OR=2.79,95%CI 0.79-10.90)。

关键数值与推荐

  • 全肠内营养对比皮质类固醇诱导缓解:OR=1.26(95%CI 0.77-2.05)。
  • 新诊断克罗恩病亚组:OR=1.61(95%CI 0.87-2.98)。
  • 复发克罗恩病亚组:OR=0.76(95%CI 0.29-1.98)。
  • 肠道愈合:OR=4.5(95%CI 1.64-12.32)。
  • CRP正常化:OR=0.85(95%CI 0.44-1.67);粪钙卫蛋白正常化:OR=2.79(95%CI 0.79-10.90)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite potential adverse-events in a paediatric population, corticosteroids are used to induce remission in paediatric Crohn's disease. Exclusive enteral nutrition also induces remission, but is infrequently used in the USA because corticosteroids are considered the superior therapy. New data have become available since the publication of the most recent meta-analysis in 2007. AIM: To see if current literature supports the use of EEN versus CS in paediatric populations. METHODS: All studies with comparator arms of exclusive enteral nutrition and an exclusive corticosteroids, with remission clearly defined were identified by searching eight online databases. RESULTS: Of 2795 identified sources, nine studies met our inclusion criteria. Eight of these (n = 451), had data that could be abstracted into our meta-analysis. Exclusive enteral nutrition was as effective as corticosteroids in inducing remission (OR = 1.26 [95% CI 0.77, 2.05]) in paediatric Crohn's disease. There was no difference between Exclusive enteral nutrition and corticosteroids efficacy when comparing newly diagnosed Crohn's (OR = 1.61 [95% CI .87, 2.98]) or relapsed (OR = 0.76 [95% CI .29-1.98]). Intestinal healing was significantly more likely among patients receiving Exclusive enteral nutrition compared to corticosteroids (OR = 4.5 [95% CI 1.64, 12.32]). There was no difference in the frequency of biomarker normalisation including CRP (OR = 0.85 [95% CI .44, 1.67]) and faecal calprotectin (OR 2.79 [95% CI .79-10.90]). CONCLUSIONS: There is no difference in efficacy between exclusive enteral nutrition and corticosteroids in induction of remission in Crohn's disease in a paediatric population. Exploratory analyses suggest that a greater proportion of patients treated with exclusive enteral nutrition achieved mucosal healing.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Swaminath A, Feathers A, Ananthakrishnan AN, et al. Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease. Aliment Pharmacol Ther. 2017. PMID: 28815649. doi:10.1111/apt.14253

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。